Centiva Capital LP cut its stake in National Health Investors, Inc. (NYSE:NHI - Free Report) by 64.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 5,786 shares of the real estate investment trust's stock after selling 10,624 shares during the period. Centiva Capital LP's holdings in National Health Investors were worth $401,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also bought and sold shares of NHI. Norges Bank purchased a new stake in National Health Investors in the fourth quarter worth about $42,322,000. Balyasny Asset Management L.P. purchased a new position in shares of National Health Investors during the fourth quarter valued at approximately $23,917,000. Marshall Wace LLP lifted its holdings in shares of National Health Investors by 161.6% during the fourth quarter. Marshall Wace LLP now owns 551,585 shares of the real estate investment trust's stock valued at $38,225,000 after purchasing an additional 340,712 shares during the last quarter. Centersquare Investment Management LLC lifted its holdings in shares of National Health Investors by 35.9% during the fourth quarter. Centersquare Investment Management LLC now owns 394,433 shares of the real estate investment trust's stock valued at $27,334,000 after purchasing an additional 104,186 shares during the last quarter. Finally, Vanguard Group Inc. lifted its holdings in shares of National Health Investors by 1.6% during the fourth quarter. Vanguard Group Inc. now owns 6,423,210 shares of the real estate investment trust's stock valued at $445,128,000 after purchasing an additional 102,012 shares during the last quarter. 62.51% of the stock is currently owned by hedge funds and other institutional investors.
National Health Investors Stock Up 1.1%
Shares of NHI traded up $0.80 on Friday, hitting $75.42. 73,365 shares of the stock traded hands, compared to its average volume of 225,074. The company has a market capitalization of $3.52 billion, a PE ratio of 25.89, a P/E/G ratio of 4.42 and a beta of 0.78. The company has a debt-to-equity ratio of 0.92, a quick ratio of 10.29 and a current ratio of 10.29. The business has a 50 day simple moving average of $74.21 and a 200 day simple moving average of $72.75. National Health Investors, Inc. has a one year low of $63.91 and a one year high of $86.13.
National Health Investors (NYSE:NHI - Get Free Report) last announced its quarterly earnings results on Monday, May 5th. The real estate investment trust reported $1.15 earnings per share for the quarter, beating the consensus estimate of $1.13 by $0.02. The company had revenue of $68.87 million during the quarter, compared to the consensus estimate of $85.13 million. National Health Investors had a net margin of 38.53% and a return on equity of 10.11%. The firm's quarterly revenue was up 9.6% compared to the same quarter last year. During the same quarter last year, the firm earned $1.10 earnings per share. As a group, equities analysts forecast that National Health Investors, Inc. will post 4.41 earnings per share for the current fiscal year.
National Health Investors Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, August 1st. Shareholders of record on Monday, June 30th will be given a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a yield of 4.77%. The ex-dividend date of this dividend is Monday, June 30th. National Health Investors's dividend payout ratio (DPR) is presently 114.29%.
Wall Street Analyst Weigh In
Several research firms have recently issued reports on NHI. Truist Financial lifted their target price on shares of National Health Investors from $70.00 to $76.00 and gave the company a "hold" rating in a report on Wednesday, March 19th. Wedbush reiterated an "outperform" rating and set a $88.00 target price on shares of National Health Investors in a report on Monday, March 17th. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $85.50.
View Our Latest Report on NHI
National Health Investors Company Profile
(
Free Report)
Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Featured Stories

Before you consider National Health Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.
While National Health Investors currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.